Symbol
| SLC10A4
| contributors: mct - updated : 08-10-2018
|
HGNC name
| solute carrier family 10 (sodium/bile acid cotransporter family), member 4
|
HGNC id
| 22980
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
|  
|  
|
results in neurotransmitter imbalance and cognitive impairment | constitutional
|  
|  
| --low
|  
|
associated with increase in the severity of AD-related neuronal degeneration | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
neurology | neurodegenerative | | |
may represent a novel target for treatment of disorders affecting motor neurons |
| | | |
| loss of Slc10a4 in mice resulted in reduced striatal serotonin, noradrenaline, and dopamine concentrations and a significantly higher dopamine turnover ratio |